Plain-English translation of NCT07276724 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called to see if it can help people with severe asthma that doesn't respond well to standard treatments. The medication is given as an injection under the skin twice over the course of a year. Researchers want to know if this treatment reduces asthma attacks and helps people breathe better.
Many people with severe asthma continue to have frequent, dangerous asthma attacks even when taking strong medications. This medication is being tested to see if it offers a new option for those who are struggling to control their symptoms with current treatments.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic for screening visits over about 2 weeks, during which you'll have breathing tests and answer questions about your asthma. If you qualify, you'll be randomly assigned to receive either the new medication or a placebo injection under your skin at the start of the study and again 6 months later. You'll return for follow-up visits over the next year to monitor your health, answer questions about your asthma symptoms, and have breathing tests repeated to see how well the treatment is working.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States